Velasco, Baby Girl -.
HRN: 21-28-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/24/2022
04/30/2022
IV
26
Q12
Sepsis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes